Sort   by:  
 Page size 
0
UnknownRET fusion gene: translation to personalized lung cancer therapy.
Not available
S-EPMC5439108 | biostudies-literature
0
UnknownBeyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.
Not available
S-EPMC4384213 | biostudies-literature
0
UnknownPresence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study.
Not available
S-EPMC7877644 | biostudies-literature
0
UnknownImmunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer.
Not available
S-EPMC8462691 | biostudies-literature
0
UnknownPrognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer.
Not available
S-EPMC9100485 | biostudies-literature
0
UnknownImmunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast.
Not available
S-EPMC8907926 | biostudies-literature
0
UnknownImmunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.
Not available
S-EPMC8195407 | biostudies-literature
0
UnknownRET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis.
Not available
S-EPMC3960615 | biostudies-literature
0
UnknownNovel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
Not available
S-EPMC9006434 | biostudies-literature
0
UnknownPD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining.
Not available
S-EPMC5533855 | biostudies-other
Sort   by:  
 Page size